thymine has been researched along with Cholera Infantum in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bendell, JC | 1 |
| Rosen, LS | 1 |
| Mayer, RJ | 1 |
| Goldman, JW | 1 |
| Infante, JR | 1 |
| Benedetti, F | 1 |
| Lin, D | 1 |
| Mizuguchi, H | 1 |
| Zergebel, C | 1 |
| Patel, MR | 1 |
| Overman, MJ | 1 |
| Kopetz, S | 1 |
| Varadhachary, G | 1 |
| Fukushima, M | 1 |
| Kuwata, K | 1 |
| Mita, A | 1 |
| Wolff, RA | 1 |
| Hoff, P | 1 |
| Xiong, H | 1 |
| Abbruzzese, JL | 1 |
| Naderi, AS | 1 |
| Farsian, FN | 1 |
| Igarashi, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Trial of TAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma[NCT04923529] | Phase 2 | 28 participants (Anticipated) | Interventional | 2021-03-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for thymine and Cholera Infantum
| Article | Year |
|---|---|
Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplasti | 2015 |
Phase I clinical study of three times a day oral administration of TAS-102 in patients with solid tumors.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Colorectal Neopl | 2008 |
1 other study available for thymine and Cholera Infantum
| Article | Year |
|---|---|
Gastrointestinal amyloidosis associated with transthyretin Phe64Ser mutation.
Topics: Adult; Amino Acid Substitution; Amyloidosis, Familial; Codon; Cytosine; DNA; Exons; Female; Gastroin | 2007 |